1. Reduced pim‑1 expression increases chemotherapeutic drug sensitivity in human androgen‑independent prostate cancer cells by inducing apoptosis
   Xing Zhang et al, 2019, Experimental and Therapeutic Medicine CrossRef
2. PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
   Sabina Luszczak et al, 2020, Signal Transduction and Targeted Therapy CrossRef
3. Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer
   Tom Malone et al, 2020, Pharmacology & Therapeutics CrossRef
4. Targeting prostate cancer via therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin
   Aanchal Rathi et al, 2024, International Journal of Biological Macromolecules CrossRef
5. Antiprostate Cancer Activity of Ineupatolide Isolated from Carpesium cernuum L.
   Yuan-she Huang et al, 2021, BioMed Research International CrossRef